loader image

Rivarospire 10, 15, 20 mg FCT

Home / Resource / Rivarospire 10, 15, 20 mg FCT

Rivarospire 10, 15, 20 mg FCT

November 16, 2021

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions.

Download File

Survey

Please fill our short Survey .

    Click Go to help us improve the world

    question title

    question title

    question title


    X
    Take Survey